Silicon Valley’s startup culture is changing—996 schedules, sober founders, and relentless focus are replacing the era of “work hard, play hard.”
China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the industry—and Washington—are rethinking the risks.
European startup funding is finding its rhythm in 2026. Here’s where you’ll find real investors, real founders, and real momentum in 2026.
In this week’s edition of The Prototype, we look at the booming space industry, better space weather forecasts, the first medical evacuation from space and more.
Tabular foundation models are the next major unlock for AI adoption, especially in industries sitting on massive databases of structured, siloed, and confidential data.
Former women’s soccer star Alex Morgan teams with forthcoming WTGL indoor simulator golf league as lead investor.
A fundamental tension is reshaping enterprise software investment, with veteran investors and AI evangelists offering starkly different visions for where lasting value will concentrate. While AI startups dominate headlines with flashy applications, vet…
In this week’s edition of InnovationRx, we look at a ‘holy grail’ pill for sleep apnea, Pomelo Care’s expansion, Nvidia and Lilly’s $1 billion AI venture, and more.
2026 Commerce predictions from top venture capitalists
AI isn’t replacing doctors—it’s fixing healthcare infrastructure. Where automation works, and why VCs are betting on scalable health tech.